After the first quarter of this year, the market turned its focus to the China Daily. According to statistics, as of May 4, a total of 1,092 companies in the Shanghai and Shenzhen stock exchanges released the results of the mid-year report, of which 755 companies were pre-happy, accounting for 69.13%.
From the perspective of sub-sectors, Pre-Happiness is mainly concentrated in the chemical, mechanical equipment, medical and biological, electronic and electrical equipment industries, with 94, 75, 68 and 59 respectively.
Among them, the pharmaceutical and biological industry has received much attention from the market. The industry believes that behind its performance pre-happiness, it is mainly affected by four aspects: First, the new medical insurance catalogue of drugs, especially in the first quarter; second, the imitation of generic drugs approved, "priority review" The effect is remarkable; the third is zero margin, the two-vote system and the new standard price reduction have weakened the marginal impact of the industry; the fourth is consumption upgrading and health awareness to drive consumption growth.
The effect of local medical insurance on the floor is significant
As the payer of drug consumption, the role of medical insurance in the sales of drugs is very obvious. If you enter the national medical insurance, you will get a national passport, which will open the sales space of medicines nationwide and achieve a growth in volume.
It is reported that 550 varieties of the 2017 national medical insurance catalogue have been added to the Shanghai medical insurance catalogue. As these varieties enter the new medical insurance catalogue, the related pharmaceutical companies will also benefit from the improved performance. The industry expects that with the arrival of medical insurance everywhere, more obvious heavy volume effects will be seen in 2018.
The approval of drugs has accelerated the “priority review†effect
With the implementation of a series of new systems for drug review and priority review in China, the enthusiasm of domestic pharmaceutical companies for the research and development of generic drugs and innovative drugs has further improved.
For example, the "Opinions on Reforming and Perfecting the Supply and Guarantee Policy of Generic Drugs" issued by China is conducive to promoting the research and development of generic drugs, improving the quality and efficacy of generic drugs, improving the supply of drugs, and accelerating the transition from a large pharmaceutical country to a pharmaceutical power.
Up to now, a total of 29 quality regulations have passed the consistency evaluation. All localities have also increased their support for the evaluation of drugs through the consistency of generic drugs.
In addition, in this context, the rate of approval of domestically imported drugs has also accelerated significantly. It is reported that in 2017, more than 20 foreign companies imported new drugs in China. After a large number of these drugs have been approved, the domestic pharmaceutical market is expected to be restructured.
Zero bonus, two-vote system and new standard price reduction
With the frequent new policies of medical reform, the "two-vote system" and "zero-plus" have become the key policies for medical reform. Under the influence of the policy of zero-addition of drugs and two-vote system, pharmaceutical companies can adopt a flexible business model. For example, we will carry out pharmaceutical logistics cooperation, carry out acquisition and integration of enterprises, and further expand the scale of the company.
Consumption upgrade and people's health awareness
In recent years, with the upgrading of consumption and the improvement of people's health awareness, people's demand for medicines and health care products has further increased. Especially with the improvement of living standards, various health foods that claim to have the function of regulating human body are increasingly favored by people, especially old consumers. This has further promoted the development of the pharmaceutical and biological industry.
In general, the current pharmaceutical bio-industry is basically oriented. The industry expects that pharmaceutical companies with small scale, backward equipment and serious pollution will be eliminated in the future, and large pharmaceutical companies will expand their market share with higher strength, thus occupying an advantage in market competition.
A Foot Spa Machine with heat is a device used to provide a relaxing and therapeutic foot massage. It usually has a basin filled with warm water and has various massage settings such as vibration, bubbles, and rollers. The heat function helps soothe tired and aching feet, while the massage setting provides a deep-tissue massage that helps improve circulation, reduce tension, and relieve pain. Some foot spas also come with removable attachments, such as pumice stones and brushes, for extra exfoliation and cleansing. Overall, a foot spa machine with heat is a great tool for anyone looking to pamper their feet and promote overall relaxation and wellness.
Foot Spa Machine With Heat,Bubble Foot Bath Massager,Foot Massage Machine,Pedicure Foot Spa Machine
Huaian Mimir Electric Appliance Co., LTD , https://www.mimirfootbath.com